Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Nov 09, 2021 10:37pm
135 Views
Post# 34108009

RE:RE:You idiots that listened to the shorts are gonna regret it

RE:RE:You idiots that listened to the shorts are gonna regret itAs to not "bury" your "very informative" post here it is again

Whether you want to believe it or not, Aristotle is generating huge buzz, better than they aniticipated.

There has been huge amounts of shares being bought between Fidelity Investments and Dejardains Financial, even as the share price trickles down, they keep bying larger lots of shares on a daily basis. They have bought over 4 million shares over the last 3 months, ever since the Care deal closed and Aristotle was released for actual purchase in September 2021.

Noone putting down that king of money wthout some insight on to what is transpiring in the background at SZLS.

You will all regret buying into the fear the shorts are trying to convey here. Notice how hard they work day in and day out to keep that fear in the air??

Tripp drops a suttle hint with his comment:

and the introduction of Aristotle and AVRT are generating the interest we anticipated amongst patients, physicians and healthcare groups. It is an exciting time for us".

Don't let the shorts try and twist this around.


Get ready for pay day!

Questions
1. Where is your proof aristotle is generating "huge buzz"
2. So you have proof that Fidelity and Dejardains themselves are buying "all these shares".  
3. Is $1.6M a "huge" amount of money for Fidelity and Dejardains or is it absolute peanuts?
4. Will we "regret" the fear Shorts have caused or are you just desperate for this to go back up at any cost.  maybe you are hoping for a whooping 10 cent flip and you have been a basher this whole time
5. Why is this "exciting time" any different than all the other "exciting times" Tripp has had.

See this is how you can see this person is a pumper and a basher.  Go ahead and say a bunch of BS and back it up in no way.


<< Previous
Bullboard Posts
Next >>